(19)
(11) EP 4 824 261 A2

(12)

(88) Date of publication A3:
21.08.2025

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24904883.6

(22) Date of filing: 12.12.2024
(51) International Patent Classification (IPC): 
C12N 15/113(2010.01)
A61K 31/712(2006.01)
A61K 31/7115(2006.01)
A61K 31/7125(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/113; C12N 2310/315; C12N 2310/322; C12N 2310/11; C12N 2310/341; C12N 2310/346
 
C-Sets:
C12N 2310/322, C12N 2310/3525;
(86) International application number:
PCT/US2024/059808
(87) International publication number:
WO 2025/128846 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 13.12.2023 US 202363609644 P

(71) Applicant: Pretzel Therapeutics, Inc.
Waltham, MA 02451 (US)

(72) Inventors:
  • XIE, Xie
    Waltham, Massachusetts 02451 (US)
  • SHI, Yonghong
    Waltham, Massachusetts 02451 (US)
  • ZHU, Xuefeng
    Waltham, Massachusetts 02451 (US)

(74) Representative: Coles, Andrea Birgit et al
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)

   


(54) OLIGONUCLEOTIDES TARGETING SAMHD1